Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI — Stella

Home/Coronary Artery Disease/NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI

View on ClinicalTrials.gov

Recruiting

Back to Coronary Artery Disease trials

NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

China

Chinese Academy of Medical Sciences, Fuwai Hospital, Beijing, Beijing Municipality

Key details

Phase

Post-approval study

Sponsor

China National Center for Cardiovascular Diseases

Enrollment target

~3,944 participants

Started

November 2023

Primary completion

December 2026

Age range

18 Years – 75 Years

Last updated January 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.